600645.SH
Vcanbio Cell & Gene Engineering Corp., Ltd.
SSE · Healthcare · Biotechnology · CN
CNY 19.23
−3.99%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 46.64x
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 79.05x
- PEG TTM
- 54.99x
- Price / book
- 2.42x
- Price / sales
- 5.99x
- Price / cash flow
- 28.82x
Enterprise value
- Enterprise value
- CNY 7.0B
- EV / sales
- 4.94x
- EV / EBITDA
- 20.52x
- EV / EBIT
- 39.33x
- Market cap
- CNY 9.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026